Press briefing on EU recommendation for COVID-19 Vaccine AstraZeneca

French is available via eTranslation, the European Commission's machine translation service.

Translate to French | Important information about machine translation

Date

Vendredi, 29 janvier 2021, Journée Entière

Lieu

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

This virtual press briefing will discuss the outcome of the evaluation of COVID-19 Vaccine AstraZeneca by EMA’s human medicines committee (CHMP).

Speakers include:

  • Emer Cooke (EMA's Executive Director)
  • Bruno Sepodes (CHMP Vice-chair)
  • Sabine Straus (PRAC Chair)
  • Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy).

Marie-Agnes Heine, EMA's Head of Communication, will moderate the press briefing.

The press briefing is held in English. 

Video recording

Share this page